American Society of Hematology

Figure 2.

$Figure 2. European Society for Medical Oncology guidelines 2017 for treatment of relapsed/refractory MM. Source: P. Moreau et al. Multiple myeloma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up, Annals of Oncology 2017;28(suppl 4):iv52–iv61; doi:10.1093/annonc/mdx096. Reproduced with permission of Oxford University Press on behalf of the European Society for Medical Oncology. Please visit: www.esmo.org.$

European Society for Medical Oncology guidelines 2017 for treatment of relapsed/refractory MM. Source: P. Moreau et al. Multiple myeloma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up, Annals of Oncology 2017;28(suppl 4):iv52–iv61; doi:10.1093/annonc/mdx096. Reproduced with permission of Oxford University Press on behalf of the European Society for Medical Oncology. Please visit: www.esmo.org.

This Feature Is Available To Subscribers Only